T. W. is receiving the chemotherapy protocol for Non-Hodgkin…
T. W. is receiving the chemotherapy protocol for Non-Hodgkin’s Lymphoma. Following the second cycle of treatment, the physician adds Neupogen (filgrastim), a colony-stimulating factor, to the regimen. The nurse would explain to T. W. that the Neupogen will:
Read Details